FDA Clears AI Tool for Coronary Plaque Analysis
The clearance enables on-premise AI analysis of coronary CT angiography for quantifying calcified and non-calcified plaque.
The clearance enables on-premise AI analysis of coronary CT angiography for quantifying calcified and non-calcified plaque.
HeartBeam announced that the FDA has granted 510(k) clearance of the HeartBeam system for comprehensive arrhythmia assessment.
Epitel's REMI Vigilenz AI For Bedside Notifications has received FDA 510(k) clearance, notifying clinicians of potential seizures.
The clearance enables on-premise AI analysis of coronary CT angiography for quantifying calcified and non-calcified plaque.
The Masimo W1 medical watch received FDA clearance for connectivity, enabling integration with the Masimo SafetyNet telemonitoring solution.
Read MoreDiality has received U.S. FDA 510(k) clearance for its Moda-flx Hemodialysis System, designed to support various dialysis treatments and improve usability across multiple care settings.
Read MoreVarian received FDA 510(k) clearance for its IntelliBlate microwave ablation system, designed for soft tissue ablation.
Read MoreRestore Medical’s ContraBand device received FDA Breakthrough Device Designation for treating heart failure with reduced ejection fraction.
Read MorePositrigo, a Swiss company, received FDA clearance for its NeuroLF brain PET system, designed to diagnose and monitor brain disorders.
Read MoreImmersiveTouch has received FDA clearance for its ImmersiveAR platform, an augmented reality technology to enhance surgical planning.
Read More
The FDA has granted 510(k) marketing clearance for AgileMD's eCART Clinical Deterioration Suite for assessing patient condition.